Intra-Cellular Therapies Inc. short interest in 2025
In 2025, Intra-Cellular Therapies Inc.'s disclosed short interest ran from 1.41% of shares outstanding on 15 Jan 2025 to 2.43% on 31 Mar 2025, a change of +1.02 percentage points. The year's high was 2.51% on 14 Mar 2025 and its low 1.41% on 15 Jan 2025, averaging 2.04% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.84 days on 31 Mar 2025. Full history: Intra-Cellular Therapies Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2025 in figures
- Start of year
- 1.41% (15 Jan 2025)
- End of year
- 2.43% (31 Mar 2025)
- Change
- +1.02 pp
- High
- 2.51% (14 Mar 2025)
- Low
- 1.41% (15 Jan 2025)
- Average
- 2.04%
- Highest days to cover
- 1.84 (31 Mar 2025)
- SEC filings marked
- 2
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 1.41% | 1.00 | |
| 31 Jan 2025 | 1.51% | 1.00 | |
| 14 Feb 2025 | 2.18% | 1.10 | |
| 28 Feb 2025 | 2.20% | 1.38 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 2.51% | 1.00 | |
| 31 Mar 2025 | 2.43% | 1.84 |
See also: Intra-Cellular Therapies Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.